MJ News and Press, ETFMG Alternative Harvest From 12/13/20

This past November, 5 additional states voted in favor of cannabis legalization ballot measures, bringing the total number of states with legal medical markets to 35 and adult-use markets to 15. Investment deals remained largely sidelined during the first half of 2020 as companies wai...

We are on the cusp of another burst of M&A in the cannabis space, but one grounded more in fiscal responsibility. Scott Hammon, partner and leader of the cannabis practice at MGO, joins us to discuss this trend and others amidst the rapidly maturing cannabis industry. Why comp...

GW Pharmaceuticals Plc is a pharma company and a global leader in developing cannabinoid-based medicines. Its multiple sclerosis drug nabiximols (brand name Sativex) was the first natural cannabis plant derivative to gain FDA approval. 2020’s US election night was a potenti...

Leading thematic ETF issuer, ETF Managers Group LLC (ETFMG®), announced today that the ETFMG Alternative Harvest ETF, better known as MJ®, has again joined the “billion-dollar club.” After less than 3 years of trading on the NYSE, MJ® achieved the impressive...

We are on the cusp of another burst of M&A in the cannabis space, but one grounded more in fiscal responsibility. Scott Hammon, partner and leader of the cannabis practice at MGO, joins us to discuss this trend and others amidst the rapidly maturing cannabis industry. Why comp...

Cantor Fitzgerald says it is growing more pessimistic about federal level cannabis reform over the next two years after what was basically a symbolic House vote on MORE last week."Recent MJ related rhetoric from Senate Majority Leader Mitch McConnell and Vice-President elect Kamala Harris, al...

Celebrating our 100th episode! Alvaro Torres, co-founder and CEO of Khiron, joins us to discuss building value in LatAm and Europe and why a strong foundation is essential. Following its recent Q3 earnings and some bullish announcements, we also cover why Khiron wanted to avoid treati...

Cannabis stocks had an uncertain reaction to the House of Representatives voting to remove marijuana from federal drug schedules under the Controlled Substances Act.The 228-164 vote in favor of legalization is a milestone, but has little chance of getting a vote on the Senate floor. Still, it...

Members of the U.S. House of Representatives are expected to cast a historic vote today on the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, which would remove pot from the U.S. list of controlled substances.The bill, would decriminalize marijuana on the federal level a...

The cannabis industry has been on a run due to Biden's win in the Presidential election. Aphria (APHA) has been one of the biggest beneficiaries, but can this performance continue? Read more to find out. Cannabis stocks have seen strong momentum over the past few weeks as investors have ...